Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116:878–98. https://doi.org/10.14309/ajg.0000000000001259.

Article  PubMed  Google Scholar 

Hayashi PH, Bjornsson ES. Long-term outcomes after drug-induced liver injury. Curr Hepatol Rep. 2018;17:292–9. https://doi.org/10.1007/s11901-018-0411-0.

Article  PubMed  PubMed Central  Google Scholar 

Hoofnagle JH, Serrano J, Knoben JE, Navarro VJ. LiverTox: a website on drug-induced liver injury. Hepatology. 2013;57:873–4. https://doi.org/10.1002/hep.26175.

Article  PubMed  Google Scholar 

Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis. 2002;22:145–55. https://doi.org/10.1055/s-2002-30105.

Article  PubMed  CAS  Google Scholar 

Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology. 2006;43:618–31. https://doi.org/10.1002/hep.21095.

Article  PubMed  Google Scholar 

Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009;29:337–47. https://doi.org/10.1055/s-0029-1240002.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Björnsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther. 2010;32:3–13. https://doi.org/10.1111/j.1365-2036.2010.04320.x.

Article  PubMed  CAS  Google Scholar 

Vega M, Verma M, Beswick D, Bey S, Hossack J, Merriman N, Shah A, Navarro V, Drug Induced Liver Injury Network (DILIN). The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of Delaware. Drug Saf. 2017;40:783–7. https://doi.org/10.1007/s40264-017-0547-9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shen T, Liu YX, Shang J, Xie Q, Li J, Yan M, Xu JM, Niu JQ, Liu JJ, Watkins PB, Aithal GP, Andrade RJ, Dou XG, Yao LF, Lv FF, Wang Q, Li YG, Zhou XM, Zhang YX, Zong PL, Wan B, Zou ZS, Yang DL, Nie YQ, Li DL, Wang YY, Han XA, Zhuang H, Ma YM, Chen CW. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology. 2019;156:2230–41. https://doi.org/10.1053/j.gastro.2019.02.002.

Article  PubMed  Google Scholar 

Zhuang MZ, Wang YP, Zhang X, Zhang ZY, Yuan RH, Zhu Y, Zhou F, Guo ZW. Clinical efficacy of Hugan Jiedu decoction against drug induced liver injury and related inflammatory cytokines (HJD). Chin J Integr Trad West Med Dig. 2016;24:26–8. https://doi.org/10.3969/j.issn.1671-038X.2016.01.07.

Article  Google Scholar 

Yang XM, Shen BR, Liu PY, Yang KN, Zhao Q, Wang ZK. Logistic regression analysis of risk factors of antituberculosis drug-induced liver injury. Chin J Hospital Pharm. 2019;39:67–71. https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2019.01.15.

Article  Google Scholar 

Sun Q, Zhang Q, Gu J, Sun WW, Wang P, Bai C, Xiao HP, Sha W. Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study. Pharmacoepidemiol Drug Saf. 2016;25:908–17. https://doi.org/10.1002/pds.3988.

Article  PubMed  CAS  Google Scholar 

He T, Wang F, Tang W. Logistic regression analysis of risk factors of antituberculosis drug-induced liver injury. China Pharm. 2016;27:1626–8. https://doi.org/10.6039/j.issn.1001-0408.2016.12.15.

Article  Google Scholar 

Xiong XM, Li L, Wang B. Progress in genetic polymorphism of drug-induced liver injury. Chin J Hospital Pharm. 2020;40:827–30. https://doi.org/10.13286/j.1001-5213.2020.07.23.

Article  CAS  Google Scholar 

Yang S, Hwang SJ, Park JY, Chung EK, Lee JI. Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. BMJ Open. 2019;9: e027940. https://doi.org/10.1136/bmjopen-2018-027940.

Article  PubMed  PubMed Central  Google Scholar 

Zhang CY, Jiao L, Bai H, Zhao ZZ, Hu XJ, Wang MJ, Wu T, Peng W, Liu TYH, Song JJ, Zhou J, Li MJ, Lyv MY, Zhang JW, Chen H, Chen J, Ying BW. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population. Infect Genet Evol. 2020;79: 104147. https://doi.org/10.1016/j.meegid.2019.104147.

Article  PubMed  CAS  Google Scholar 

Fernández-Villar A, Sopeña B, Fernández-Villar J, Vázquez-Gallardo R, Ulloa F, Leiro V, Mosteiro M, Piñeiro L. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. Int J Tuberc Lung Dis. 2004;8(12):1499–505.

PubMed  Google Scholar 

Jussi JS, David LC, Robert MJ, Steven S, John AJ, Charles MN, Charles AP, Fred MG, David N, Dorothy BS, John B, Raman V, Timothy RS, ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935–52. https://doi.org/10.1164/rccm.200510-1666ST.

Article  CAS  Google Scholar 

Zhang L, Zhu JY. Research progress of anti tuberculosis drug-induced liver injuries. Jiangxi Med J. 2019;54(9):1139–41. https://doi.org/10.3969/j.issn.1006-2238.2019.9.049.

Article  Google Scholar 

Zhang HJ, Shi ZX, Zhao LF, Gao TH, Li J. Analysis of clinical characteristics of 56 cases of liver injury caused by antitumor drugs. J Clin Hepatobiliary Dis. 2019;35:574–578. CNKI:SUN:LCGD.0.2019-03-105.

González J, Quiroga M, Escudero-Vilaplana V, Collado-Borrell R, Herranz-Alonso A, Sáez MS. Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities. Expert Opin Drug Saf. 2018;17:553–72. https://doi.org/10.1080/14740338.2018.1477937.

Article  PubMed  CAS  Google Scholar 

Xie ZZ, Liang Y, Sun LL. Evaluation of antitumor drug hepatotoxicity and dose adjustment in patients with impaired liver function. Chin J Clin Pharmacol. 2016;32:2203–5. https://doi.org/10.13699/j.cnki.1001-6821.2016.23.023.

Article  Google Scholar 

Zhu SS, Chen X, Yan QY, Lin Z. Progress in clinical application of anti-tumor drugs. China Modern Doctor. 2019;57(9):164–8.

Google Scholar 

Han LN. Clinical study on integrated backscatter parameters in assessment of hepatic and renal toxicity by symphysicchemotheraphy (paclitaxel and cisplatin). Dalian: Dalian Medical University; 2008.

Google Scholar 

Yan X, Deng Y, Ma J, Li PJ, Yang ZJ, Yang XJ, Zhou Y. Research advance in mechanism of cisplatin toxic injury and its prevention and treatment by traditional chinese medicine. Chin J Exp Tradit Med Formulae. 2021;27(5):233–42. https://doi.org/10.13422/j.cnki.syfjx.20202460.

Article  Google Scholar 

Sun B, Li XY, Liu GL. Research progress on drug-induced liver injury related to non-steroidal anti-inflammatory drugs.World Chin J Digestion. 2015;23:3053–3059. CNKI:SUN:XXHB.0.2015-19-011.

Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology. 2010;39:1430–40. https://doi.org/10.1002/hep.20205.

Article  CAS  Google Scholar 

Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2003;7:351–67. https://doi.org/10.1016/j.cld.2007.06.006.

Article  Google Scholar 

Li HY, Yang CP, Jin HT. Recent research progress in mechanism of liver injury induced by common drugs. Chin J Pharmacovigilance. 2019;16:750–6. https://doi.org/10.19803/j.1672-8629.2019.12.09.

Article  Google Scholar 

Seif A, Howida S. Physiological changes due to hepatotoxicity and the protective role of some medicinal plants. Beni-Suef Univ J Basic Appl Sci. 2016;5(2):134–46. https://doi.org/10.1016/j.bjbas.2016.03.004.

Article  Google Scholar 

Divya S, William CC, Ghanshyam U. Drug-induced liver toxicity and prevention by herbal antioxidants: an overview. Front Physiol. 2016;6:363. https://doi.org/10.3389/fphys.2015.00363.

Article  Google Scholar 

Jack A, Angela BR, Sandra SMC, Laura PJ. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev. 2004;36(3–4):805–22. https://doi.org/10.1081/dmr-200033494.

Article  Google Scholar 

Jennifer SA, Paul JP. Drug-induced liver injury from antiepileptic drugs. Clin Liver Dis. 2013;17:687–97. https://doi.org/10.1016/j.cld.2013.07.011.

Article  Google Scholar 

Huang J, Ren N. Study progress of liver injury induced by antiepileptics. J Appl Clin Pediatr. 2007;22(6):465–7.

CAS  Google Scholar 

Michael PH, Cynthia J. Mech Drug Induced Liver injury. AAPSJ. 2006;8(1):E48-54. https://doi.org/10.1208/aapsj080106.

Article  Google Scholar 

Karima B, Anissa I, Dominique P, Bernard F. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006;6(1):1–28. https://doi.org/10.1016/j.mito.2005.10.004.

Article  CAS  Google Scholar 

Nie XL, Tao QM, Zhan SY, Wang D, Wu GZ, Cheng G. Systematic review of risk factors of oral ketoconazole hepatotoxicity. Chin J Pharmacovigilance. 2012;9:460–3. https://doi.org/10.3969/j.issn.1672-8629.2012.08.004.

Article  Google Scholar 

Rodriguez RJ, Acosta D. Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. Drug Metab Dispos. 1997;25:772–7. https://doi.org/10.1016/S1246-7391(99)80028-1.

Article  PubMed  CAS  Google Scholar 

Meng PP, Liu SK, He Y, Ma YT, Zuo SR, Song LY, Wang CJ. Analysis of clinical characteristics and influencing factors of 144 cases of drug-induced liver injury. Chin J Clin Pharmacol. 2017;33(467–469):473. https://doi.org/10.13699/j.cnki.1001-6821.2017.05.023.

Article  Google Scholar 

Byeon JH, Kil JH, Ahn YC, Son CG. Systematic review of published data on herb induced liver injury. J Ethnopharmacol. 2019;233:190–6. https://doi.org/10.1016/j.jep.2019.01.006.

Article  PubMed  Google Scholar 

He S, Zhang C, Zhou P, Zhang XL, Ye TY, Wang RY, Sun GB, Sun XB. Herb-induced liver injury: phylogenetic relationship, structure-toxicity relationship, and herb-ingredient network analysis. Int J Mol. 2019;20:3633. https://doi.org/10.3390/ijms20153633.

Article  CAS  Google Scholar 

Norman BH. Drug Induced Liver Injury (DILI). Mechanisms and medicinal chemistry avoidance/mitigation strategies. J Med Chem. 2020;63:11397–419. https://doi.org/10.1021/acs.jmedchem.0c00524.

Article  PubMed  CAS  Google Scholar 

Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89:95–106. https://doi.org/10.1016/j.mayocp.2013.09.016.

Article  PubMed  CAS  Google Scholar 

Li F, Dong YZ, Zhang D, Zhang XM, Lin ZJ, Zhang B. Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: a network pharmacology study and biology experiments. PLoS ONE. 2019;14(5): e0216948. https://doi.org/10.1371/journal.pone.0216948.

Article  PubMed